Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
about
MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenograftsBCRP Inhibition: from Data Collection to Ligand-Based Modeling.Scaffold identification of a new class of potent and selective BCRP inhibitors.Optimization of Acryloylphenylcarboxamides as Inhibitors of ABCG2 and Comparison with Acryloylphenylcarboxylates.Acryloylphenylcarboxamides: A New Class of Breast Cancer Resistance Protein (ABCG2) Modulators.
P2860
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@ast
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@en
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@nl
type
label
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@ast
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@en
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@nl
prefLabel
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@ast
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@en
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.
@en
P2093
Federico Marighetti
Kerstin Steggemann
Markus Hanl
Michael Wiese
P2860
P304
P356
10.1002/CMDC.201200377
P577
2012-11-13T00:00:00Z